ClinicalTrials.Veeva

Menu

Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection (FMT)

University of California Irvine (UCI) logo

University of California Irvine (UCI)

Status

Completed

Conditions

Clostridium Difficile Infection

Treatments

Biological: Fecal Microbial Transplantation

Study type

Observational

Funder types

Other

Identifiers

NCT02326636
20139455

Details and patient eligibility

About

The purpose of this research is to investigate the efficacy of transplanting screened donor fecal material in treating patients with recurrent Clostridium difficile infection. Participants with refractory Clostridium difficile infection will be given healthy donor stool administered by colonoscopy or enema and their response will be evaluated by symptom questionnaire and stool testing for Clostridium difficile at 4 weeks after the treatment.

Enrollment

37 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for Recipient:

  • Between the age of 18 and 100
  • Have positive Clostridium difficile polymerase chain reaction (PCR) or toxin
  • Have symptoms of > 3 watery loose stools a day for at least 2 consecutive days
  • Have failed at least one prior standard course of antibiotic therapy.

Examples of standard therapy are:

  • Metronidazole 500 mg three times a day for 10 to 14 days
  • Vancomycin 125 mg four times a day for 10 to 14 days
  • Not be pregnant and have negative urine and/or serum human chorionic gonadotropin (hCG) test
  • Not be taking oral or intravenous steroids in the past three months.
  • Not on biologic agents, anti-tumor necrosis factor (anti-TNF) agents, cyclosporine, mercaptopurine, azathioprine, methotrexate or chemotherapy in the preceding 3 months
  • Not have profound immunosuppression: Chemotherapy the preceding 3 months, HIV/AIDS, decompensated cirrhosis
  • Not be in the Intensive Care Unit
  • Not be a transplant recipient

Exclusion Criteria for Recipient:

  • Not between the age of 18 and 100
  • Does not have positive Clostridium difficile PCR or toxin
  • Does not have symptoms of > 3 watery loose stools a day for at least 2 consecutive days
  • Has not failed at least one prior standard course of antibiotic therapy. Examples of standard therapy are:
  • Metronidazole 500 mg three times a day for 10 to 14 days
  • Vancomycin 125 mg four times a day for 10 to 14 days
  • Is pregnant
  • Has taken oral or IV steroids in the past three months.
  • Has taken biologic agents, anti-TNF agents, cyclosporine, mercaptopurine, azathioprine, methotrexate or chemotherapy in the preceding 3 months
  • Has profound immunosuppression: Chemotherapy the preceding 3 months, HIV/AIDS, decompensated cirrhosis
  • In the Intensive Care Unit
  • Is a transplant recipient

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems